CVR - Coronavirus Vaccines R&D Roadmap

Virology Applicable to Vaccine Development

Milestones not started
1
Milestones in progress
12
Milestones completed
1
Strategic goal
1.1

SARS-CoV-2 variant data

Enhance and sustain the capacity to identify, characterize, and share SARS-CoV-2 variants of interest, concern, and high consequence among researchers globally.

1.1.a

Biosafety levels

1.1.b

Sequencing capacity

1.1.c

Genomic data standards

1.1.d
High priority

Real-time assessment

Strategic goal
1.2

Coronavirus characterization

Improve characterization of coronaviruses to better understand the breadth of coverage needed for broadly protective vaccines. 

1.2.a

Specimen biosafety

1.2.b

Animal sampling

1.2.c
High priority

Breadth-of-protection panel

1.2.d

Reagent availability

1.2.e
High priority

Virus stock panel

1.2.f

Metagenomic sequencing studies

1.2.g

Metagenomic sequencing methods

1.2.h

Sequence data sharing

Strategic goal
1.3

Coronavirus virology

Improve understanding of coronavirus virology to better inform spillover and emergence risk.

1.3.a

Host-cell receptors

1.3.b

Infectivity, transmission, and virulence